Early Phase 1 Type 1 Diabetes Clinical Trials
5 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
Effect of C-peptide on Hypoglycemic Counterregulation
Type 1 DiabetesHypoglycemia
University of Cincinnati38 enrolled1 locationNCT06470295
Recruiting
Early Phase 1
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Type 1 Diabetes
Vanderbilt University Medical Center24 enrolled1 locationNCT06338553
Recruiting
Early Phase 1
Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
Healthy VolunteerMODY2 DiabetesType 1 Diabetes Mellitus+1 more
Vanderbilt University Medical Center27 enrolled1 locationNCT06609356
Recruiting
Early Phase 1
The Effects of Fluoxetine and/or DHEA
Type 1 Diabetes Mellitus
University of Maryland, Baltimore60 enrolled1 locationNCT03228732
Recruiting
Early Phase 1
Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
Type 1 Diabetes
Augusta University24 enrolled1 locationNCT04449198